COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
19
08
2020
accepted:
11
03
2021
revised:
04
02
2021
pubmed:
12
5
2021
medline:
9
9
2021
entrez:
11
5
2021
Statut:
ppublish
Résumé
Delivering lung cancer care during the COVID-19 pandemic has posed significant and ongoing challenges. There is a lack of published COVID-19 and lung cancer evidence-based reviews, including for the whole patient pathway. We searched for COVID-19 and lung cancer publications and brought together a multidisciplinary group of stakeholders to review and comment on the evidence and challenges. A rapid review of the literature was undertaken up to 28 October 2020, producing 144 papers, with 113 full texts screened. We focused on new primary data collection (qualitative or quantitative evidence) and excluded case reports, editorials and commentaries. Following exclusions, 15 published papers were included in the review and are summarised. They included one qualitative paper and 14 quantitative studies (surveys or cohort studies), with a total of 2295 lung cancer patients data included (mean study size 153 patients; range 7-803). Review of current evidence and commentary included awareness and help-seeking; lung cancer screening; primary care assessment and referral; diagnosis and treatment in secondary care, including oncology and surgery; patient experience and palliative care. Cross-cutting themes and challenges were identified using qualitative methods for patients, healthcare professionals and service delivery, with a clear need for continued studies to guide evidence-based decision-making.
Identifiants
pubmed: 33972746
doi: 10.1038/s41416-021-01361-6
pii: 10.1038/s41416-021-01361-6
pmc: PMC8108433
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
629-640Subventions
Organisme : Medical Research Council
ID : MR/T02481X/1
Pays : United Kingdom
Organisme : DH | NIHR | Research Trainees Coordinating Centre (NIHR Research Trainees Coordinating Centre)
ID : DRF-2016-09-054
Organisme : RCUK | MRC | Medical Research Foundation
ID : MR/T02481X/1
Informations de copyright
© 2021. The Author(s), under exclusive licence to Cancer Research UK.
Références
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
pubmed: 31986264
pmcid: 7159299
doi: 10.1016/S0140-6736(20)30183-5
World Health Organization (WHO). Global Cancer Statistics (WHO, 2018).
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M. et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391, 1023–1075 (2018).
pubmed: 29395269
pmcid: 5879496
doi: 10.1016/S0140-6736(17)33326-3
Arnold, M., Rutherford, M. J., Bardot, A., Ferlay, J., Andersson, T. M., Myklebust, T. Å. et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 20, 1493–1505 (2019).
pubmed: 31521509
pmcid: 6838671
doi: 10.1016/S1470-2045(19)30456-5
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386 (2015).
pubmed: 25220842
doi: 10.1002/ijc.29210
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 21, 335–337 (2020).
pubmed: 32066541
pmcid: 7159000
doi: 10.1016/S1470-2045(20)30096-6
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J. et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J. Infect. 81, e16–e25 (2020).
Public Health England (PHE). Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19 (2020).
NHS England. Cancer Waiting Times; Monthly Provider Based Data and Summaries (NHS England, 2020).
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S. et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ open. 10, e043828 (2020).
Sud, A., Jones, M., Broggio, J., Loveday, C., Torr, B., Garrett, A. et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann. Oncol. 31, 1065–1074 (2020).
Richards, M., Anderson, M., Carter, P., Ebert, B. L. & Mossialos, E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 1, 565–567 (2020).
Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis: a national population based modelling study. Lancet Oncol. 21, 1023–1034 (2020).
Sud, A., Torr, B., Jones, M. E., Broggi, J., Scott, S., Loveday, C., Garrett, A., Gronthoud, F., Nicol, D. L., Jhanji, S., Boyce, S. A., Williams, A., Riboli, E., Muller, D. C., Kipps, E., Larkin, J., Navani, N., Swanton, C., Lyratzopoulos, G., McFerran, E., Lawler, M., Houlston, R. & Turnbull, C. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 21, 1034–1044 (2020).
UK Lung Cancer Coalition (UKLCC). COVID-19 Matters: A Review of the Impact of COVID-19 on the Lung Cancer Pathway and Opportunities for Innovation Emerging from the Health System Response to the Pandemic COVID-19 (UKLCC, 2020).
Birt, L., Hall, N., Emery, J., Banks, J., Mills, K., Johnson, M. et al. Responding to symptoms suggestive of lung cancer: a qualitative interview study. BMJ Open Respir. Res. 1, e000067 (2014).
McLachlan, S., Mansell, G., Sanders, T., Yardley, S., Van der Windt, D., Brindle, L. et al. Symptom perceptions and help-seeking behaviour prior to lung and colorectal cancer diagnoses: a qualitative study. Fam. Pract. 32, 568–577 (2015).
pubmed: 26099812
pmcid: 4576759
doi: 10.1093/fampra/cmv048
Hannaford, P. C., Thornton, A. J., Murchie, P., Whitaker, K. L., Adam, R. & Elliott, A. M. Patterns of symptoms possibly indicative of cancer and associated help-seeking behaviour in a large sample of United Kingdom residents—The USEFUL study. PLoS ONE 15, e0228033 (2020).
pubmed: 31978177
pmcid: 6980617
doi: 10.1371/journal.pone.0228033
Cunningham, Y., Wyke, S., Blyth, K. G., Rigg, D., Macdonald, S., Macleod, U. et al. Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: a qualitative interview study. Psycho‐oncology 28, 718–725 (2019).
pubmed: 30693608
pmcid: 6492269
doi: 10.1002/pon.5005
Quaife, S. L., Marlow, L. A., McEwen, A., Janes, S. M. & Wardle, J. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect. 20, 563–573 (2017).
pubmed: 27397651
doi: 10.1111/hex.12481
McCutchan, G., Smits, S., Ironmonger, L., Slyne, C., Boughey, A., Moffat, J. et al. Evaluation of a national lung cancer symptom awareness campaign in Wales. Br. J. Cancer 122, 491–497 (2020).
pubmed: 31839675
doi: 10.1038/s41416-019-0676-2
Malhotra, J., Malvezzi, M., Negri, E., La Vecchia, C. & Boffetta, P. Risk factors for lung cancer worldwide. Eur. Respir. J. 48, 889–902 (2016).
pubmed: 27174888
doi: 10.1183/13993003.00359-2016
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N. et al. The impact of COPD and smoking history on the severity of COVID‐19: a systemic review and meta‐analysis. J. Med. Virol. 92, 1915–21 (2020).
de Joode, K., Dumoulin, D., Engelen, V., Bloemendal, H., Verheij, M., van Laarhoven, H. et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur. J. Cancer 136, 132–139 (2020).
pubmed: 32683273
pmcid: 7334940
doi: 10.1016/j.ejca.2020.06.019
Medicine, T. L. R. COVID-19 casts light on respiratory health inequalities. Lancet Respir. Med. 8, 743 (2020).
doi: 10.1016/S2213-2600(20)30308-8
Ironmonger, L., Ohuma, E., Ormiston-Smith, N., Gildea, C., Thomson, C. & Peake, M. An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom. Br. J. Cancer 112, 207–216 (2015).
pubmed: 25461805
doi: 10.1038/bjc.2014.596
Public Health England (PHE). National Cancer Registration and Analysis Service (NCRAS). Be clear on cancer: regional and national lung cancer awareness campaigns 2011 to 2014. Final evaluation results. 2018. http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/be_clear_on_cancer/ .
Ali, N., Lifford, K. J., Carter, B., McRonald, F., Yadegarfar, G., Baldwin, D. R. et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open 5, e008254 (2015).
Crosbie, P. A., Balata, H., Evison, M., Atack, M., Bayliss-Brideaux, V., Colligan, D. et al. Implementing lung cancer screening: baseline results from a community-based ‘Lung Health Check’pilot in deprived areas of Manchester. Thorax 74, 405–409 (2019).
pubmed: 29440588
doi: 10.1136/thoraxjnl-2017-211377
Mazzone, P. J., Gould, M. K., Arenberg, D. A., Chen, A. C., Choi, H. K., Detterbeck, F. C. et al. Management of lung nodules and lung cancer screening during the COVID-19 pandemic: CHEST expert panel report. Chest 158, 406–15 (2020).
Chung, R. Y.-N., Dong, D. & Li, M. M. Socioeconomic gradient in health and the COVID-19 outbreak. BMJ 369, m1329 (2020). https://doi.org/10.1136/bmj.m1329 .
Hamilton, W. Five misconceptions in cancer diagnosis. Br. J. Gen. Pract. 59, 441–447 (2009).
pubmed: 19520027
pmcid: 2688046
doi: 10.3399/bjgp09X420860
Hamilton, W. & Sharp, D. Diagnosis of lung cancer in primary care: a structured review. Fam. Pract. 21, 605–611 (2004).
pubmed: 15520035
doi: 10.1093/fampra/cmh605
Round, T., Gildea, C., Ashworth, M. & Møller, H. Association between use of urgent suspected cancer referral and mortality and stage at diagnosis: a 5-year national cohort study. Br. J. Gen. Pract. 70, e389–e398 (2020).
pubmed: 32312762
pmcid: 7176359
doi: 10.3399/bjgp20X709433
Elliss-Brookes, L., McPhail, S., Ives, A., Greenslade, M., Shelton, J., Hiom, S. et al. Routes to diagnosis for cancer–determining the patient journey using multiple routine data sets. Br. J. Cancer 107, 1220–1226 (2012).
pubmed: 22996611
pmcid: 3494426
doi: 10.1038/bjc.2012.408
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P. et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med. Infect. Dis. 101623 (2020).
Lyratzopoulos, G., Abel, G., McPhail, S., Neal, R. & Rubin, G. Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br. J. Cancer 108, 686–690 (2013).
pubmed: 23392082
pmcid: 3593564
doi: 10.1038/bjc.2013.1
Swann, R., McPhail, S., Witt, J., Shand, B., Abel, G. A., Hiom, S. et al. Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit. Br. J. Gen. Pract. 68, e63–e72 (2018).
pubmed: 29255111
doi: 10.3399/bjgp17X694169
Majeed, A., Maile, E. J. & Bindman, A. B. The primary care response to COVID-19 in England’s National Health Service. J. R. Soc. Med. 113, 208–210 (2020).
pubmed: 32521196
pmcid: 7439588
doi: 10.1177/0141076820931452
Helsper, C. W., Campbell, C., Emery, J., Neal, R. D., Li, L., Rubin, G. et al. Cancer has not gone away: a primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19. Eur. J. Cancer Care 29, e13290 (2020).
Khan, N., Jones, D., Grice, A., Alderson, S., Bradley, S., Carder, P. et al. A brave new world: the new normal for general practice after the COVID-19 pandemic. BJGP Open 4, bjgpopen20X101103 (2020).
Royal College of General Pracititioners (RCGP). COVID-19 Resource Hub. https://www.rcgp.org.uk/covid-19.aspx (2020).
Jones, D., Neal, R. D., Duffy, S. R., Scott, S. E., Whitaker, K. L. & Brain, K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. Lancet Oncol. 21, 748 (2020).
pubmed: 32359404
pmcid: 7251992
doi: 10.1016/S1470-2045(20)30242-4
Maconachie, R., Mercer, T., Navani, N. & McVeigh, G. Lung cancer: diagnosis and management: summary of updated NICE guidance. BMJ 364, 11049 (2019). https://doi.org/10.1136/bmj.l1049 .
British Thoracic Society. COVID-19: information for the respiratory community. https://www.brit-thoracic.org.uk/about-us/covid-19-information-for-the-respiratory-community/ (2020).
Munro, A. & Swartzman, S. What is a virtual multidisciplinary team (vMDT)? Br. J. Cancer 108, 2433–2441 (2013).
pubmed: 23756866
pmcid: 3694234
doi: 10.1038/bjc.2013.231
Passaro, A., Addeo, A., Von Garnier, C., Blackhall, F., Planchard, D., Felip, E. et al. ESMO management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open 5(Suppl. 3), e000820 (2020).
pubmed: 32581069
pmcid: 7319703
doi: 10.1136/esmoopen-2020-000820
Horn, L., Whisenant, J. G., Torri, V., Huang, L.-C., Trama, A., Paz-Ares, L. G. et al. Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): impact of type of cancer therapy and COVID therapy on survival. Am. Soc. Clin. Oncol. 38, LBA111 (2020).
Albiges, L., Foulon, S., Bayle, A., Gachot, B., Pommeret, F., Willekens, C. et al. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort. Nat. Cancer 1, 965–975 (2020).
doi: 10.1038/s43018-020-00120-5
pubmed: 35121871
Luo, J., Rizvi, H., Preeshagul, I. R., Egger, J. V., Hoyos, D., Bandlamudi, C. et al. COVID-19 in patients with lung cancer. Ann. Oncol. 31, 1386–1396 (2020).
pubmed: 32561401
doi: 10.1016/j.annonc.2020.06.007
National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: delivery of systemic anticancer treatments https://www.nice.org.uk/guidance/ng161/chapter/6-Prioritising-systemic-anticancer-treatments (2020).
National Institute for Health and Care Excellence (NICE). Interim treatment change options during the COVID-19 pandemic, endorsed by NHS England. https://www.nice.org.uk/guidance/ng161/resources/interim-treatment-change-options-during-the-covid19-pandemic-endorsed-by-nhs-england-pdf-8715724381 (2020).
Faivre-Finn, C., Fenwick, J. D., Franks, K. N., Harrow, S., Hatton, M. Q., Hiley, C. et al. Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clin. Oncol. 32, 481–9 (2020).
Lei, S., Jiang, F., Su, W., Chen, C., Chen, J., Mei, W. et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 100331 (2020).
Unit NGHR. About CovidSurg. https://globalsurg.org/covidsurg/ (2020).
Nepogodiev, D., Glasbey, J. C., Li, E., Omar, O. M., Simoes, J. F., Abbott, T. E. et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an International Cohort study. Lancet 396, 27–38 (2020).
Royal College of Surgeons (RCS). Coronavirus (COVID-19) Information Hub. https://www.rcseng.ac.uk/coronavirus/ (2020).
Glasbey, J. C., Bhangu, A., Collaborative C. Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study. J. Clin. Oncol. 20.01933 (2020).
Kasivisvanathan, V., Lindsay, J., Rakshani-Moghadam, S., Elhamshary, A., Kapriniotis, K., Kazantzis, G. et al. A cohort study of 30 day mortality after non-emergency surgery in a COVID-19 cold site. Int. J. Surg. 84, 57–65 (2020).
pubmed: 33122153
pmcid: 7584883
doi: 10.1016/j.ijsu.2020.10.019
Thoracic Surgery Outcomes Research Network, I., Antonoff, M., Backhus, L., Boffa, D. J., Broderick, S. R., Brown, L. M. et al. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. J. Thorac. Cardiovasc. Surg. 160, 601–605 (2020).
doi: 10.1016/j.jtcvs.2020.03.061
Etkind, S. N., Bone, A. E., Lovell, N., Cripps, R. L., Harding, R., Higginson, I. J. et al. The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the COVID-19 pandemic. J. Pain Symptom Manage. 60, e31–e40 (2020).
Temel, J. S., Greer, J. A., El-Jawahri, A., Pirl, W. F., Park, E. R., Jackson, V. A. et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J. Clin. Oncol. 35, 834 (2017).
pubmed: 28029308
doi: 10.1200/JCO.2016.70.5046
Chou, Y.-C., Yen, Y.-F., Feng, R.-C., Wu, M.-P., Lee, Y.-L., Chu, D. et al. Impact of the COVID-19 pandemic on the utilization of hospice care services: a Cohort Study in Taiwan. J. Pain Symptom Manage. 60, e1-6 (2020).
Brighton, L. J., Miller, S., Farquhar, M., Booth, S., Yi, D., Gao, W. et al. Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis. Thorax 74, 270–281 (2019).
pubmed: 30498004
doi: 10.1136/thoraxjnl-2018-211589
Hospice UK. ‘The Conversation’: COVID-19 resources collection. https://www.hospiceuk.org/docs/default-source/echo/covid-19-echo/the-conversation_resources_collection_24june2020.pdf?sfvrsn=2 (2020).
Johnson, H., Brighton, L. & Clark J. Experiences, Concerns, and Priorities for Palliative Care Research During the Covid-19 Pandemic: A Rapid Virtual Stakeholder Consultation with People Affected by Serious Illness in England (King’s College London, 2020).
Miaskowski, C., Paul, S. M., Snowberg, K., Abbott, M., Borno, H., Chang, S. et al. Stress and symptom burden in oncology patients during the COVID-19 pandemic. J. Pain Symptom Manage. 60, e25–e34 (2020).
pubmed: 32889039
pmcid: 7462969
doi: 10.1016/j.jpainsymman.2020.08.037
Marron, J. M., Joffe, S., Jagsi, R., Spence, R. A. & Hlubocky, F. J. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic. J. Clin. Oncol. 38, 2201–2205 (2020).
pubmed: 32343643
doi: 10.1200/JCO.20.00960
Higginson, I. J. M. M., Bayly, J., Brighton, L. J., Hutchinson, A., Booth, S., Ogden, M. & Farquhar, M. Managing breathlessness at home during the COVID-19 outbreak. https://www.kcl.ac.uk/cicelysaunders/resources/khp-gp-breathlessness-resource.pdf (2020).
Higginson, I., Murtagh, F., Preston, N., Sleeman, K., Maddocks, M., Bajwah, S., Fraser, L., Hocaoglu, M., Oluyase, A., Walshe, C. Improving palliative care for people affected by the COVID-19 pandemic by sharing learning – the National and International response. https://www.kcl.ac.uk/cicelysaunders/research/evaluating/covpall-study (2020).
Thomas, J. & Harden, A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med. Res. Methodol. 8, 45 (2008).
Gebbia, V., Piazza, D., Valerio, M. R., Borsellino, N. & Firenze, A. Patients with cancer and COVID-19: a WhatsApp messenger-based survey of patients’ queries, needs, fears, and actions taken. JCO Glob. Oncol. 6, 722–729 (2020).
pubmed: 32412811
doi: 10.1200/GO.20.00118
Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R. et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 31, 894–901 (2020).
pubmed: 32224151
doi: 10.1016/j.annonc.2020.03.296
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z. et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 10, 783–791 (2020).
pubmed: 32345594
pmcid: 7309152
Garassino, M. C., Whisenant, J. G., Huang, L. C., Trama, A., Torri, V., Agustoni, F. et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 21, 914–922 (2020).
pubmed: 32539942
pmcid: 7292610
doi: 10.1016/S1470-2045(20)30314-4
Ghosh, J., Ganguly, S., Mondal, D., Pandey, P., Dabkara, D. & Biswas, B. Perspective of oncology patients during COVID-19 pandemic: a prospective observational study from India. JCO Glob. Oncol. 6, 844–851 (2020).
pubmed: 32552110
doi: 10.1200/GO.20.00172
Rogado, J., Pangua, C., Serrano-Montero, G., Obispo, B., Marino, A. M., Pérez-Pérez, M. et al. Covid-19 and lung cancer: a greater fatality rate? Lung Cancer 146, 19–22 (2020).
pubmed: 32505076
doi: 10.1016/j.lungcan.2020.05.034
Sha, Z., Chang, K., Mi, J., Liang, Z., Hu, L., Long, F. et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann. Palliat. Med. 9, 3373–3378 (2020).
pubmed: 33065788
doi: 10.21037/apm-20-1662
Calles, A., Aparicio, M. I., Alva, M., Bringas, M., Gutierrez, N., Soto, J. et al. Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid. Front. Oncol. 10, 1777 (2020).
pubmed: 33042826
pmcid: 7525070
doi: 10.3389/fonc.2020.01777
Leclère, J. B., Fournel, L., Etienne, H., Al Zreibi, C., Onorati, I., Roussel, A. et al. Maintaining surgical treatment of non-small cell lung cancer during the COVID-19 pandemic in Paris. Ann. Thorac. Surg. (2020). https://doi.org/10.1016/j.athoracsur.2020.08.007 .
Zhang, Y. J., Yang, W. J., Liu, D., Cao, Y. Q., Zheng, Y. Y., Han, Y. C. et al. COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study. Transl. Lung Cancer Res. 9, 1516–1527 (2020).
pubmed: 32953523
pmcid: 7481645
doi: 10.21037/tlcr-20-892
Fu, R., Wu, L., Zhang, C., Chu, Q., Hu, J., Lin, G. et al. Real-world scenario of patients with lung cancer amid the Coronavirus Disease 2019 pandemic in the People’s Republic of China. JTO Clin. Res. Rep. 1, 100053 (2020).
pubmed: 32929416
pmcid: 7239012
Fujita, K., Ito, T., Saito, Z., Kanai, O., Nakatani, K. & Mio, T. Impact of COVID-19 pandemic on lung cancer treatment scheduling. Thorac Cancer 11, 2983–2986 (2020).
pubmed: 32790028
pmcid: 7436133
doi: 10.1111/1759-7714.13615
Hyland, K. A. & Jim, H. S. L. Behavioral and psychosocial responses of people receiving treatment for advanced lung cancer during the COVID-19 pandemic: a qualitative analysis. Psychooncology 29, 1387–1392 (2020). https://doi.org/10.1002/pon.5445 .
Yang, K., Sheng, Y., Huang, C., Jin, Y., Xiong, N., Jiang, K. et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 21, 904–913 (2020).
pubmed: 32479787
pmcid: 7259917
doi: 10.1016/S1470-2045(20)30310-7